Why is Torrent Pharma falling/rising?

As of 13-Aug, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,609.10, which reflects a decrease of 17.6 points or 0.49%. Today's price summary indicates that the stock has underperformed its sector by 1.98% and has seen a trend reversal after two consecutive days of gains. Despite this recent downturn, the stock has shown strong performance over the past week, with a return of 2.36%, and has outperformed the benchmark Sensex over the last month and year-to-date, with returns of 9.13% and 7.56%, respectively. The company maintains a high management efficiency with a return on capital employed (ROCE) of 22.33%, a low debt to EBITDA ratio of 1.26 times, and has reported positive results for the last eight consecutive quarters, which supports its overall stability and growth potential.
In the broader market context, while Torrent Pharmaceuticals has shown strong returns compared to the Sensex over various periods, the recent decline in stock price may be attributed to falling investor participation, as indicated by a 17.86% drop in delivery volume against the five-day average. This decline in trading activity could signal a lack of confidence among investors, despite the company's solid fundamentals and consistent performance over the years. The stock's liquidity remains adequate for trading, but the recent underperformance relative to its sector may be contributing to the current price movement.